Phase Two Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Exthymic Corporationexthymic.cominApr 2024
Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.
BiotechHealthtechSan Diego, US
Rich Stoner(Founder)inDan Knudsen(Founder)Kevin Cooksy(Founder)in
Co-investorsHAWKTAILKdT Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

